LifePoint Health Reports Second Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Mizuho Securities Cuts Price Target on LifePoint Health (LPNT) to $93 Following 2Q
August 3, 2015 7:43 AM EDTMizuho Securities reiterates a Buy rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $93.00 (from $95.71), following its 2Q report. Analyst Sheryl Skolnick asked LPNT, is growth in inpatient admits really as crucial to the success of hospitals in the current... More
LifePoint Health (LPNT) Tops Q2 EPS by 1c; Guides FY15 Revenue Ahead of Expectations
July 31, 2015 7:04 AM EDTLifePoint Health (NASDAQ: LPNT) reported Q2 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.24 billion.
LifePoint Health sees FY2015 EPS of $3.75 - $4.06, versus the consensus of $4.00. LifePoint Health sees FY2015... More
